Higher revenues in its dosimetry and accelerator product lines propelled radiopharmaceutical provider Ion Beam Applications (IBA) to positive financial results in the first quarter (end-31 March).
Revenues increased 4% to 46.3 million euros, compared with 42.9 million euros in the first quarter of 2013.
The company anticipates growth in revenues this year of 5% to 10%, with service revenues expected to reach approximately 61 million euros in 2014.
